Huadong Medicine is a leading Chinese pharmaceutical company specializing in the research, development, production, and distribution of innovative medicines. The company is dedicated to advancing healthcare through effective therapeutic solutions across various medical fields, contributing to global patient health.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Huadong Medicine is scheduled to report its next quarterly earnings on 08/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Huadong Medicine last reported quarterly earnings on 4/24/2026 (Q1 2026). Earnings per share (EPS) came in at 0.51 CNY.
Huadong Medicine has beaten analyst EPS estimates in 0 of its last 4 evaluated quarters (beat rate: 0%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.